Effect of S-ketamine in Cesarean Section Combined Anesthesia
Launched by THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Jun 8, 2022
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • ASA status I-III
- • Age 20 to 45
- • 37-42 weeks gestation
- • undergo elective cesarean section with subarachnoid anesthesia
- • participate in this study and sign informed consent
- Exclusion Criteria:
- • Patients with contraindications for cesarean section
- • Patients with contraindications of combined spinal and epidural anesthesia
- • Patients with severe systemic disease
- • Alcoholism and long-term use of anti-inflammatory and analgesic drugs
- • Patients who were unable to cooperate or refused to participate in the trial
- • Patients with contraindications to esketamine and hydromorphone
About The Second Affiliated Hospital Of Chongqing Medical University
The Second Affiliated Hospital of Chongqing Medical University is a leading healthcare institution dedicated to advancing medical research and patient care through innovative clinical trials. As a prominent academic hospital in China, it combines cutting-edge medical technology with a strong emphasis on education and training for healthcare professionals. The hospital is committed to conducting high-quality, ethically sound clinical research that contributes to the development of new therapies and enhances healthcare outcomes. With a multidisciplinary team of experts, the Second Affiliated Hospital fosters collaboration and strives to address critical health challenges through rigorous scientific investigation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chongqing, Chongqing, China
Patients applied
Trial Officials
HUANG HE, MD
Study Director
Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials